JP
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals develops first-in-class therapeutics targeting difficult-to-drug oncology pathways, utilizing its proprietary drug discovery platforms, including iADC and induced-fit technology. The company focuses on addressing the unmet medical needs in cancer treatment through innovative combination therapies and has multiple projects in advanced clinical stages.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Jacobio Pharmaceuticals develops first-in-class therapeutics targeting difficult-to-drug oncology pathways, utilizing its proprietary drug discovery platforms, including iADC and induced-fit technology. The company focuses on addressing the unmet medical needs in cancer treatment through innovative combination therapies and has multiple projects in advanced clinical stages.